Treatment of Acute Cholecystitis
Early laparoscopic cholecystectomy is the treatment of choice for acute cholecystitis, ideally performed within 7-10 days of symptom onset, with appropriate antibiotic therapy based on disease severity. 1
Initial Assessment and Management
Diagnosis
- Ultrasonography is the first-line imaging technique
- Key findings: gallbladder wall thickening, pericholecystic fluid, distended gallbladder, positive sonographic Murphy's sign 1
Initial Medical Management
- Fasting
- Intravenous fluid resuscitation
- Pain management
- NSAIDs as first-line therapy
- Acetaminophen as alternative or adjunct
- Oral opioids for breakthrough pain 1
- Low-fat diet during acute phase with small, frequent meals when oral intake is resumed 1
Definitive Treatment
Surgical Management
Early Laparoscopic Cholecystectomy
Interval Cholecystectomy
- When early surgery is not feasible
- Schedule after 6-12 weeks from symptom onset to allow inflammation to resolve 1
Percutaneous Cholecystostomy
Antibiotic Therapy
Uncomplicated Acute Cholecystitis
- Class A or B patients with successful cholecystectomy:
Complicated Acute Cholecystitis
Class A or B patients:
- Cholecystectomy as urgent procedure
- Short course postoperative antibiotic therapy (1-4 days) 2
Class C patients:
- Emergent cholecystectomy with postoperative antibiotic therapy
- Duration based on clinical improvement 2
Empiric Antibiotic Options
Mild to moderate cases:
- Amoxicillin/Clavulanate 875mg/125mg orally every 12 hours
- Ciprofloxacin 500 mg every 12 hours plus Metronidazole 500 mg every 8 hours 1
Severe or critically ill patients:
- Piperacillin/tazobactam 6g/0.75g loading dose then 4g/0.5g q6h or 16g/2g by continuous infusion
- Eravacycline 1 mg/kg every 12 hours
- Tigecycline 100 mg loading dose then 50 mg every 12 hours 1
Duration of Therapy
- Uncomplicated cholecystitis: 4 days total
- Complicated cholecystitis or immunocompromised patients: up to 7 days total 1
Special Considerations
Elderly Patients
- Higher risk for complications
- May require more cautious antibiotic management due to:
- Changes in pharmacokinetics and pharmacodynamics
- Potential drug interactions
- Renal effects of coexisting diseases 2
Patients with Multidrug-Resistant Organisms
- Consider antibiotic resistance in patients from healthcare facilities or nursing homes
- Obtain intraoperative cultures to guide antibiotic therapy 1
Monitoring and Follow-up
- Monitor for signs of ongoing infection:
- Fever
- Worsening abdominal pain
- Purulent drainage from surgical sites
- Increasing white blood cell count 1
- Discontinue antibiotics when:
- Patient is afebrile for 24 hours
- White blood cell count normalizes
- No signs of ongoing infection 1
Pitfalls to Avoid
- Delaying surgical intervention beyond 10 days from symptom onset
- Continuing broad-spectrum antibiotics unnecessarily after source control
- Overlooking complications such as gangrenous, hemorrhagic, or emphysematous cholecystitis
- Failing to adjust antibiotic therapy based on culture results when available
- Underestimating the need for multidisciplinary management in critically ill patients 2, 1